Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2024-01-10 00:00:00 ET · period of report 2024-01-09 · accession 0001628280-24-001074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-10 | 2024-01-09 | LFCR | Calloway Nathaniel | Dir | M - OptEx | — | +5,906 | 24.1K | +32% | — |
| D | 2024-01-10 | 2024-01-09 | LFCR | Calloway Nathaniel | Dir | M - OptEx | $0.00 | -5,906 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-09 | M | A | 5,906 | — | 24,088 | D | — | — | (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. |
| 2 | Derivative | Restricted Stock Unit | 2024-01-09 | M | D | 5,906 | $0.00 | 0 | D | — · 2024-01-09 to — | 5,906 Common Stock | (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. (F2) The restricted stock units vested on January 9, 2024. |